Related Experiment Video
Updated: Aug 14, 2026

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Biological aspects of monocyte chemoattractant protein-1 (MCP-1)
E J Leonard1, A Skeel, T Yoshimura
1Immunopathology Section, National Cancer Institute, Frederick, Maryland.
Insights
Monocyte chemoattractant protein-1 (MCP-1) may mediate cellular infiltration in delayed-type hypersensitivity (DCH) by attracting monocytes and basophils. Further research is needed to explore lymphocyte responses to MCP-1.
Area of Science:
- Immunology
- Cellular Biology
- Dermatology
Background:
- Delayed-type hypersensitivity (DCH) is characterized by mononuclear leukocyte infiltration without neutrophils.
- The specific mediators of cellular infiltration in DCH are not fully understood.
Purpose of the Study:
- To investigate the role of Monocyte Chemoattractant Protein-1 (MCP-1) as a mediator of cellular infiltration in DCH.
- To determine if lymphocytes and antigen stimulation can induce MCP-1 production.
- To assess the chemoattractant properties of MCP-1 for different leukocyte types.
Main Methods:
- Preliminary data analysis from experiments involving PHA-stimulated lymphocytes.
- Observation of MCP-1 production in response to antigen stimulation.
- Assessment of MCP-1's effect on monocyte, basophil, and neutrophil migration.
Main Results:
- Preliminary data suggest PHA-stimulated lymphocytes secrete MCP-1.
- MCP-1 production can be induced by antigen stimulation.
- MCP-1 attracts monocytes and basophils, but not neutrophils.
Conclusions:
- MCP-1 is a potential mediator of cellular infiltration in DCH.
- The differential attraction of leukocytes by MCP-1 aligns with the observed infiltration patterns in DCH.
- Further investigation into lymphocyte responses to MCP-1 and conditions favoring selective agonist secretion is warranted.
Abstract:
In this communication, we have asked if MCP-1 is the mediator of cellular infiltration in DCH, outlining the criteria in Table 3. Preliminary data suggest that PHA-stimulated lymphocytes secrete MCP-1, and that MCP-1 can be produced in response to antigen stimulation. MCP-1 attracts monocytes and basophils, but not neutrophils. The question of a lymphocyte response to MCP-1 requires further study. We have emphasized that the discovery of leukocyte-specific NAP-1 and MCP-1 should now be followed by exploration of conditions in which one agonist is secreted without the other. This would be expected, for example, in DCH, which is characterized by mononuclear leukocyte infiltration without neutrophils.

